Table 1. Patients characteristics.
Group P (prednisolone) n=5 | Group C (curcumin) n=5 | Group N (No therapy) n=5 | p-value | |
PREOPERATIVE | ||||
Ratio of male/female | 4/1 | 3/2 | 4/1 | 0.31 |
Patient age in years | 64.9±3 | 70.1±5 | 69.4±9 | 0.74 |
Preoperative flare in pc/ms | 18.7±2.2 | 22.8±5.6 | 19.2±1.4 | 0.52 |
Preoperative IOP | 19±1.5 | 15±1.2 | 15±2.2 | 0.14 |
Number of days of symptoms until surgery | 4.9±2.0 | 5.6±1.5 | 4.7±1.2 | 0.75 |
Preoperative phak/pseudophak | 2/3 | ¼ | 1/4 | 0.2 |
Number of foramina | 2.4±1.8 | 2.1±0.9 | 2.3±1.7 | 0.76 |
POSTOPERATIVE | ||||
Postoperative PVR development | 1/5* | 0/5 | 0/5 | 0.27 |
Flare in pc/ms, two weeks | 5.1±2.7 | 5.2±1.3 | 5.0±1.8 | 0.82 |
VA in logMAR, six months | 0.56±0.31 | 0.53±0.19 | 0.53±0.17 | 0.44 |